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Procedure
Methyl (S)-2-((tert-Butoxycarbonyl)amino)-3-(7-(4,4,5,5-tetramethyl-1,3,2-dioxa-borolan-2-
yl)-1H-indol-3-yl)propanoate (3)
A flame-dried, 500-mL two-necked round-bottomed flask, equipped with a 3.5 cm football-
shaped magnetic stir bar and thermometer, is charged with N-Boc-L-tryptophan methyl ester 
(1, 6.31 g, 19.8 mmol, 1.0 equiv), (1,5-cyclooctadiene)(methoxy)iridium(I) dimer (328 mg, 
0.500 mmol, 0.025 equiv), and 4,4'-di-tert-butyl-2,2'-bipyridine (266 mg, 0.991 mmol, 0.05 
equiv) (Note 1). The flask is sealed with a rubber septum secured by copper wire and placed 
under a nitrogen atmosphere after three successive vacuum–argon cycles conducted slowly 
using a needle inlet through the septum (Figure 1). Fresh anhydrous tetrahydrofuran (180 
mL) (Note 2) is introduced into the flask via a syringe to afford a dark brown solution. 
Using a syringe, 4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2, 14.4 mL, 99.1 mmol, 5.00 
equiv) (Note 1) is added in a single portion, whereupon the solution rapidly changes color 
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1N-Boc-L-Tryptophan methyl ester (99%) was used as purchased from Chem-Impex International, Inc. 4,4,5,5-Tetramethyl-1,3,2-
dioxaborolane (97%), (1,5-cyclooctadiene)(methoxy)iridium(I) dimer and 4,4'-di-tert-butyl-2,2'-bipyridine (98%) were used as 
purchased from Sigma Aldrich Chemical Company, Inc. Palladium(II) acetate (98%) was used as purchased from Strem Chemicals, 
Inc. Acetic acid, glacial (ACS grade) was used as purchased from Fisher Scientific.
2THF was purchased from Fisher Scientific and purified by the method of Grubbs et al.3 under positive argon pressure.
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from brown to dark red. This reaction solution is stirred and maintained at 60 °C. After 13 h, 
TLC analysis indicates complete consumption of starting material 1 (Notes 3 and 4).
The reaction solution is cooled to 23 °C, and is concentrated under reduced pressure (20 
mmHg, 30 °C) to afford a dark brown residue. Acetic acid (20.0 mL) (Note 1) is slowly 
added to this residue to give a brown solution, followed by addition of palladium(II) acetate 
(223 mg, 0.991 mmol, 0.05 equiv) (Note 1) in a single-portion. The mixture is stirred under 
a nitrogen atmosphere at 30 °C for 12 h (Note 5), at which time TLC analysis indicates 
complete consumption of the 2,7-diboronated intermediate. The reaction mixture is then 
cooled to 23 °C, filtered through Celite using a glass-sintered funnel (9 cm diameter, 4 cm 
height), and the filter cake is rinsed with ethyl acetate (3 × 150 mL). The filtrate is washed 
with saturated aqueous sodium bicarbonate (500 mL), the layers are separated, and the 
aqueous layer is extracted with ethyl acetate (2 × 300 mL). The organic layers are combined, 
dried over anhydrous sodium sulfate (15 g), filtered, and concentrated under reduced 
pressure (20 mmHg, 30 °C). The resulting brown residue is purified by flash column 
chromatography on silica gel (eluent: 5% acetone, 15% dichloromethane, 80% hexanes) 
(Note 6) to provide a light yellow solid. The solid is recrystallized (Note 7) to afford N-
Boc-7-boro-L-tryptophan methyl ester 3 as a white powdery solid 4.09–4.29 g (46.5–48.8%) 
(Notes 8 and 9) (Figure 2).
3Thin layer chromatography was performed using pre-coated (0.25 mm) silica gel 60 F-254 plates purchased from SiliCycle (eluent: 
5% acetone, 15% dichloromethane, 80% hexanes): Compound 1 Rf = 0.06 (CAM, UV), Compound 3 Rf = 0.17 (CAM, UV), 
Compound 4 Rf = 0.26 (CAM, UV).4The intermediate N-Boc-2,7-diborotryptophan methyl ester (4, see Scheme 2) could be isolated in ca. 88% yield as a white solid, by 
flash column chromatography over silica gel (eluent: 5% acetone, 15% dichloromethane, 80% hexanes) (Note 6) of the crude mixture 
after the diboronation step (see Discussion section, Scheme 2). This product contained trace impurities (<5%) but was not subjected to 
further chromatographic purification due to its sensitivity toward C2 protodeboronation. For reference, data for N-Boc-2,7-
diborotryptophan methyl ester (4) is as follows: 1H NMR (500 MHz, CDCl3, 20 °C) δ: 1.33 (s, 9H), 1.39 (s, 18H), 1.40 (s, 6H), 3.33 
(dd, J = 14.0, 10.0 Hz, 1H), 3.46 (dd, J = 14.0, 4.5 Hz, 1H), 3.70 (s, 3H), 4.36–4.28 (m, 1H), 6.00 (d, J = 6.8 Hz, 1H), 7.11 (t, J = 7.2 
Hz, 1H), 7.70 (d, J = 6.8 Hz, 1H), 7.77 (d, J = 8.0 Hz, 1H), 9.21 (br-s, 1H); 13C NMR (125 MHz, CDCl3, 20 °C) δ: 24.9, 25.2, 27.4, 
28.2, 28.5, 52.3, 55.5, 79.4, 84.0, 84.6, 119.4, 123.1, 123.2, 127.0, 131.9, 143.1, 155.9, 173.7; FTIR (neat) cm−1: 3451 (br-s), 2979 
(s), 1751 (s), 1718 (s), 1596 (m), 1558 (s), 1436 (m), 1368 (m), 1293 (s), 1167 (m), 1135 (s), 1050 (m), 851 (m); HRMS (ESI, TOF) 
(m/z) calc’d for C29H44B2N2O8Na [M+Na]+: 593.3202, found: 593.3204; mp 105–106 °C;5Longer exposure to these protodeboronation conditions led to isolation of trace amounts (<5%) of N-Boc-L-tryptophan methyl ester 
(1), resulting from proto-deboronation of product 3.
6Flash column chromatography (9.0 cm diameter, 17 cm height) was performed using silica gel (60-Å pore size, 40–63 µm, standard 
grade, Zeochem). The residue was loaded using dichloromethane (15 mL). After 500 mL of initial elution, fraction collection (50 mL 
fractions) is begun, and elution is continued with 2.7 L of eluent (5% acetone, 15% dichloromethane, 80% hexanes). The compound 3 
is obtained in fractions 21–54.
7The chromatographed product was poured into a 125 mL Erlenmeyer flask and 30 mL of hexanes/chloroform (3:1) was added. The 
mixture was heated to its boiling point (70 °C), and 5 mL portions of hexanes/chloroform (3:1) were added until the total volume was 
55 mL (the solid was not completely dissolved). The mixture was cooled to 23 °C, capped and left to stand for 13 h, then placed in a 
fridge at 4 °C for 48 h. The recrystallized solid was then filtered with a glass-sintered funnel, washing 3 times with cooled hexanes.
8The analytical data for tryptophan derivative 3 is as follows: 1H NMR NMR (500 MHz, CDCl3) δ: 1.39 (s, 12H), 1.43 (s, 9H), 3.30 
(d, J = 5.4 Hz, 1H), 3.67 (s, 3H), 4.63 (dt, J = 8.5, 5.3 Hz, 1H) 5.06 (d, J = 8.2 Hz, 1H), 7.06 (s, 1H), 7.13 (t, J = 7.5 Hz, 1H), 7.64 (d, 
J = 7.0 Hz, 1H), 7.67 (d, J = 7.9 Hz, 1H), 9.13 (br-s, 1H, N1H); 13C NMR (125 MHz, CDCl3) δ: 25.1, 28.0, 28.4, 52.3, 54.4, 79.8, 
83.9, 109.6, 119.2, 122.4, 122.9, 126.7, 129.6, 141.4, 155.3, 172.8. FTIR (neat) cm−1: 3384 (br-s), 2979 (m), 1740 (s), 1701 (s), 1592 
(m), 1503 (s), 1438 (m), 1371 (m), 1334 (m), 1165 (m), 1130 (s), 1052 (m), 970 (s), 920 (s), 849 (m), 760 (s), 684(s); HRMS (ESI, 
TOF) (m/z) calc’d for C23H33BN2O6 [M+H]+: 445.2510, found: 445.2508; mp 179–181 °C; Anal. calc’d for C23H33BN2O6: C, 
62.17; H, 7.49; N, 6.30, found: C, 61.80; H, 7.23; N, 6.12. TLC (5% acetone, 15% dichloromethane, 80% hexanes), Rf = 0.17 (CAM, 
UV).
9Mosher ester analysis provided an enantiomeric excess of >98% for the alcohol obtained from reduction of a sample of ester 1 that 
had been made by protodeboronation of 7-borotryptophan 3 (see Note 5). This is in full agreement with the expectation that this 
procedure does not erode the enantiopurity of 7-borotryptophan 3 with respect to tryptophan 1.
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Handling and Disposal of Hazardous Chemicals
The procedures in this article are intended for use only by persons with prior training in 
experimental organic chemistry. All hazardous materials should be handled using the 
standard procedures for work with chemicals described in references such as "Prudent 
Practices in the Laboratory" (The National Academies Press, Washington, D.C., 2011 
www.nap.edu). All chemical waste should be disposed of in accordance with local 
regulations. For general guidelines for the management of chemical waste, see Chapter 8 of 
Prudent Practices.
In some articles in Organic Syntheses, chemical-specific hazards are highlighted in red 
“Caution Notes” within a procedure. It is important to recognize that the absence of a 
caution note does not imply that no significant hazards are associated with the chemicals 
involved in that procedure. Prior to performing a reaction, a thorough risk assessment should 
be carried out that includes a review of the potential hazards associated with each chemical 
and experimental operation on the scale that is planned for the procedure. Guidelines for 
carrying out a risk assessment and for analyzing the hazards associated with chemicals can 
be found in Chapter 4 of Prudent Practices.
These procedures must be conducted at one's own risk. Organic Syntheses, Inc., its Editors, 
and its Board of Directors do not warrant or guarantee the safety of individuals using these 
procedures and hereby disclaim any liability for any injuries or damages claimed to have 
resulted from or related in any way to the procedures herein.
Discussion
Indole derivatives are prevalent in many natural products and pharmaceutical compounds, 
mostly in the form of often-complex tryptophan and tryptamine-derived motifs.4 The 
demand for such diversely substituted indole structures has led to the development of a wide 
range of methods for indole functionalization.5 With regards to tryptophan and tryptamine 
derivatives, selective functionalization at indole C7 has proven especially difficult, with few 
methods available that are direct and readily scalable.6 We sought to explore a direct C7 
functionalization method for 3-substituted indoles by utilizing arene C–H boronation as a 
means to this end.7 Of particular relevance to us were reports into iridium-catalyzed indole 
boronations,8 which Smith had initially shown in 2006 would proceed selectively at C7 with 
C2-substituted indoles.8a These studies inspired us to investigate a more streamlined process 
for direct C7 boronation of tryptophan and tryptamine substrates in a single operation. By 
taking advantage of the more nucleophilic/basic C2 position of C3-substituted indoles, our 
two-step single-flask procedure provides expedient access to the corresponding C7-
boronated compounds on multi-gram scale through direct C7 activation of non-
functionalized tryptamines and tryptophans.9 The premise behind this diboronation/
protodeboronation sequence was our recognition of the high propensity of five-membered 
heterocycles to undergo rapid C2 protodemetalation.10
Examination of conditions for the diboronation of various N-protected tryptamines 
demonstrated that exposure to excess pinacolborane (5 equiv), catalytic amounts of 
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[Ir(cod)OMe]2, and 4,4’-di-tert-butylbipyridine in tetrahydrofuran at 60 °C, was sufficient to 
ensure full boronation at C2 and C7.9 Consistent with our C2 protodeboronation hypothesis, 
these 2,7-diboronated indoles can be dissolved in dichloromethane followed by addition of 
trifluoroacetic acid to cleanly afford the desired 7-boronated indole derivatives.
As we were interested in converting these two steps into a single-flask operation, we first 
explored simple acidification of the reaction medium once the diboronation was complete. 
However, mere addition of an equivolume (with respect to tetrahydrofuran) of 
trifluoroacetic acid at 0 °C led to global protodeboronation and recovery of starting material. 
Gratifyingly, dilution of the reaction mixture with dichloromethane followed by the addition 
of trifluoroacetic acid at 0 °C, led to the desired C2-protodeboronated tryptamine in 60% 
yield for the two-step process (entry 1, Table 1).9
We then focused our attention on expanding the substrate scope (Table 1) to other 3-
substituted indoles. In all but one case (entry 1), a temperature of 60 °C and reaction time of 
4–7 h was found to be ideal for the diboronation reactions (entries 2–5, Table 1).9 These 
results highlighted the general compatibility of our protocol with alcohol, carbamate, ester, 
and sulfonamide functional groups. The excellent yield obtained for a C7-boronated 
tryptophan derivative (entry 4, Table 1) and its ready conversion to the corresponding 7-
halo, 7-hydroxy and 7-aryl tryptophan derivatives (Scheme 1) further highlight the 
versatility of this chemistry.9
The 2,7-diborotryptophan 4 (Scheme 2), resulting from C2/C7 diboronation of N-Boc 
tryptophan methyl ester (1) using our standard iridium-catalyzed conditions,9 could be 
isolated chromatographically (ca. 88%, Note 4) from the crude reaction mixture after 
removal of volatiles.
We have developed milder conditions than those described in Table 1 for the C2 
protodeboronation of the intermediate 2,7-diborotryptophan 4. After exploring a range of 
additives in acetic acid, it was found that C2-selective protodeboronation of 2,7-
diborotryptophan 4 could be engendered by inclusion of catalytic quantities of palladium(II) 
acetate. The optimal temperature for this step was found to be 30 °C, delivering the desired 
N-Boc 7-borotryptophan methyl ester 3 in 85% yield (Scheme 2). Further still, the dried 
crude mixture from the diboronation step could also be subjected to the same palladium-
catalyzed protodeboronation conditions, once more rendering this a two-step single-flask 
operation as described above.9
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Appendix
Chemical Abstracts Nomenclature (Registry Number)
N-Boc-L-Tryptophan methyl ester: L-Tryptophan, N-[(1,1- dimethylethoxy)carbonyl]- 
(13139-14-5) (1,5-Cyclooctadiene)(methoxy)iridium(I) dimer: bis[(1,2,5,6-η)-1,5-
cyclooctadiene]di-μ-methoxydi-; (12148-71-9) 4,4'-Di-tert-butyl-2,2'-bipyridine: 2,2'-
Bipyridine, 4,4'-bis(1,1-dimethylethyl)-; (72914-19-3) 4,4,5,5-Tetramethyl-1,3,2-
dioxaborolane: 1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-; (25015-63-8) Palladium(II) 
acetate: Acetic acid, palladium(2+) salt (2:1); (3375-31-3)
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Figure 1. 
Reaction Apparatus (photo provided by checkers)
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Figure 2. 
Reaction Product 3 (photo provided by authors)
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Scheme 1. 
Representative derivatization of a C7-boronated tryptophan
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Scheme 2. 
Two step sequence for C7 boronation of N-Boc tryptophan 1
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Table 1
Rapid synthesis of C7-boronated 3-substituted indole derivatives
a
Isolated yield after purification.
b
Boronation conducted at 80 °C.
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c2nd step: Pd(OAc)2 (5 mol%), AcOH, 30 °C.
dGram-scale reaction.
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